Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial - Clarke, NW; Ali, A; Ingleby, FC (Ann Oncol, 2019)
et al.